Ryan Allway October 1st, 2021 Psychedelics An expert panel will present and discuss new potential treatments for Alcohol Use Disorder and binge drinking TORONTO, Oct. 01, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the “Company“), a psychedelic medicine biotech company focused on... Read more